1. Home
  2. Alle Unternehmen
  3. Lumos Pharma
  4. Kennzahlen
  5. EBITDA per Share
Lumos Pharma logo
Lumos Pharma LUMO

Quartalsbericht 2024-Q3
hinzugefügt 30.05.2026

report update icon

Lumos Pharma EBITDA per Share 2011-2026 | LUMO

EBITDA per Share Jährlich Lumos Pharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999
-4.49 -3.82 -3.74 -3.79 -7.51 -0.26 -2.28 -3.06 -1.12 4.26 -1.2 -1.08 -2.87 -4.77 -3.18 - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
4.26 -7.51 -2.59

EBITDA per Share Vierteljährlich Lumos Pharma

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-0.92 -0.96 -1.34 - -1.12 -1.18 -0.97 - -0.9 -0.95 -0.92 - -0.87 -0.96 -1.02 - -0.82 -0.79 -2.35 -7.38 -0.39 -0.28 -0.28 -0.29 -0.38 -0.46 -0.49 -0.38 -0.66 -0.55 -0.71 -0.48 -0.53 -1.15 -0.86 -0.51 -0.51 -0.53 0.47 5.33 -0.44 -0.31 -0.33 -0.3 -0.29 -0.26 -0.33 -0.3 -0.25 -0.29 -0.23 -0.28 -0.94 -1.11 -1.02

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
5.33 -7.38 -0.662

EBITDA per Share anderer Aktien in der Pharmaeinzelhändler

Name EBITDA per Share Preis % 24h Marktkapitalisierung Land
FSD Pharma FSD Pharma
HUGE
 		-0.71 - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
 		-15.2 - 2.43 % $ 254 M germanyGermany
Compugen Ltd. Compugen Ltd.
CGEN
 		0.34 $ 2.02 -0.98 % $ 189 M israelIsrael
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		-0.82 - 1.35 % $ 17.8 M chinaChina
Coherus BioSciences Coherus BioSciences
CHRS
 		-1.54 $ 1.42 - $ 166 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		-2.35 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
 		0.08 - - $ 866 M chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		-2.46 - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		6.75 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
 		-2.24 - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
 		-0.03 - -13.47 % $ 169 M franceFrance
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		-0.87 - - $ 2.17 B usaUSA
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited
ASLN
 		-0.09 - -14.27 % $ 1.7 M singaporeSingapore
AstraZeneca PLC AstraZeneca PLC
AZN
 		12.6 - - $ 96.9 B britainBritain
CureVac N.V. CureVac N.V.
CVAC
 		0.79 - - $ 867 M germanyGermany
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.22 - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
 		-23.7 - - $ 269 M usaUSA
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
 		-3.51 - 0.74 % $ 768 M israelIsrael
Abcam plc Abcam plc
ABCM
 		-0.04 - - $ 4.9 B britainBritain
Galera Therapeutics Galera Therapeutics
GRTX
 		-0.03 - -32.59 % $ 7.61 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		-0.03 - -18.52 % $ 27.3 M britainBritain
Affimed N.V. Affimed N.V.
AFMD
 		-0.54 - -34.95 % $ 21.5 M germanyGermany
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
 		-7.17 $ 51.48 -0.23 % $ 4.63 B schweizSchweiz
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		-2.69 - - - russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		-2.84 - - $ 231 M usaUSA
Celyad Oncology SA Celyad Oncology SA
CYAD
 		-1.81 - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
 		-1.29 - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
 		-4.28 $ 29.6 3.64 % $ 1.97 B usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
 		-2.06 - - $ 344 M usaUSA
IMV IMV
IMV
 		-0.28 - - $ 13.1 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
 		-4.25 - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
 		-2.45 - 0.23 % $ 488 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		-2.42 - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		-3.85 - -4.36 % $ 27 M usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
 		-1.63 - - $ 384 M britainBritain
Gracell Biotechnologies Gracell Biotechnologies
GRCL
 		-1.67 - - $ 3.37 B chinaChina
Anika Therapeutics Anika Therapeutics
ANIK
 		-0.4 $ 14.57 -0.21 % $ 209 M usaUSA
Advaxis Advaxis
ADXS
 		-5.96 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		-3.37 - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		-6.7 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		-0.36 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		-3.89 - 1.93 % $ 17.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		-6.03 $ 2.91 -5.52 % $ 4.79 M israelIsrael
Aptose Biosciences Aptose Biosciences
APTO
 		0.01 - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
 		-0.92 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		-6.41 - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
 		-3.02 - 4.14 % $ 49.1 M usaUSA
Allakos Allakos
ALLK
 		-1.29 - - $ 28.6 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		-0.09 $ 22.79 5.8 % $ 2.9 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
 		-0.14 - 3.16 % $ 1.9 M usaUSA